These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8144952)
1. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor. Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952 [TBL] [Abstract][Full Text] [Related]
2. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules. Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035 [TBL] [Abstract][Full Text] [Related]
3. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548 [TBL] [Abstract][Full Text] [Related]
4. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Dennig D; Yan Y; Ferguson K; O'Reilly RJ Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788 [TBL] [Abstract][Full Text] [Related]
5. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells. Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255 [TBL] [Abstract][Full Text] [Related]
6. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain. Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208 [TBL] [Abstract][Full Text] [Related]
7. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390 [TBL] [Abstract][Full Text] [Related]
8. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells. Wen R; Blackman MA; Woodland DL J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239 [TBL] [Abstract][Full Text] [Related]
9. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells. Imanishi K; Igarashi H; Uchiyama T J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens. Abe R; Foo-Phillips M; Granger LG; Kanagawa O J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235 [TBL] [Abstract][Full Text] [Related]
11. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles. Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953 [TBL] [Abstract][Full Text] [Related]
12. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules. Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143 [TBL] [Abstract][Full Text] [Related]
13. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Maillard I; Erny K; Acha-Orbea H; Diggelmann H Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159 [TBL] [Abstract][Full Text] [Related]
14. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. Surman S; Deckhut AM; Blackman MA; Woodland DL J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210 [TBL] [Abstract][Full Text] [Related]
15. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases. Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929 [TBL] [Abstract][Full Text] [Related]
16. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice. Anderson GD; Banerjee S; David CS J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186 [TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
18. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Brogan PA; Shah V; Klein N; Dillon MJ Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503 [TBL] [Abstract][Full Text] [Related]
19. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge. Fattorossi A; Baschieri S; Ferlini C; Doria G Thymus; 1997; 24(3):133-45. PubMed ID: 9151379 [TBL] [Abstract][Full Text] [Related]
20. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen. Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]